B Lymphocyte-Induced Maturation Protein-1 Contributes to Intestinal Mucosa Homeostasis by Limiting the Number of IL-17-Producing CD4(+) T Cells


Autoria(s): Salehi, Soofia; Bankoti, Rashmi; Benevides, Luciana; Witten, Jessica; Couse, Michael; Silva, Joao S.; Dhall, Deepti; Meffre, Eric; Targan, Stephan; Martins, Gistaine A.
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

01/11/2013

01/11/2013

2012

Resumo

The transcription factor B lymphocyte induced maturation protein-1 (Blimp-1) plays important roles in embryonic development and immunity. Blimp-1 is required for the differentiation of plasma cells, and mice with T cell specific deletion of Blimp-1 (Blimp-1CKO mice) develop a fatal inflammatory response in the colon. Previous work demonstrated that lack of Blimp-1 in CD4(+) and CD8(+) T cells leads to intrinsic functional defects, but little is known about the functional role of Blimp-1 in regulating differentiation of Th cells in vivo and their contribution to the chronic intestinal inflammation observed in the Blimp1CKO mice. In this study, we show that Blimp-1 is required to restrain the production of the inflammatory cytokine IL-17 by Th cells in vivo. Blimp-1CKO mice have greater numbers of IL-17 producing TCR beta(+)CD4(+)cells in lymphoid organs and in the intestinal mucosa. The increase in IL-17 producing cells was not restored to normal levels in wild-type and Blimp-1CKO mixed bone marrow chimeric mice, suggesting an intrinsic role for Blimp-1 in constraining the production of IL-17 in vivo. The observation that Blimp-1 deficient CD4(+) T cells are more prone to differentiate into IL-17(+)/IFN-gamma(+) cells and cause severe colitis when transferred to Rag1-deficient mice provides further evidence that Blimp-1 represses IL-17 production. Analysis of Blimp-1 expression at the single cell level during Th differentiation reveals that Blimp-1 expression is induced in Th1 and Th2 but repressed by TGF-beta in Th17 cells. Collectively, the results described here establish a new role for Blimp-1 in regulating IL-17 production in vivo. The Journal of Immunology, 2012,189: 5682-5693.

National Institutes of Health-National Institute of Allergy and Infectious Diseases [AI083948-01]

National Institutes of HealthNational Institute of Allergy and Infectious Diseases

F. Widjaja Foundation Inflammatory Bowel and Immunobiology Institute

F. Widjaja Foundation Inflammatory Bowel and Immunobiology Institute

Fundacao de Amparo a Pesquisa e ao Ensino do Estado de Sao Paulo (Brazil) (FAPESP) [2008/04606-2]

Fundacao de Amparo a Pesquisa e ao Ensino do Estado de Sao Paulo (Brazil) (FAPESP)

Identificador

JOURNAL OF IMMUNOLOGY, BETHESDA, v. 189, n. 12, supl. 1, Part 3, pp. 5682-5693, DEC 15, 2012

0022-1767

http://www.producao.usp.br/handle/BDPI/37478

10.4049/jimmunol.1201966

http://dx.doi.org/10.4049/jimmunol.1201966

Idioma(s)

eng

Publicador

AMER ASSOC IMMUNOLOGISTS

BETHESDA

Relação

JOURNAL OF IMMUNOLOGY

Direitos

restrictedAccess

Copyright AMER ASSOC IMMUNOLOGISTS

Palavras-Chave #ROR-GAMMA-T #TRANSCRIPTIONAL REPRESSOR BLIMP-1 #HUMAN TH17 CELLS #LINEAGE DIFFERENTIATION #T(H)17 CELLS #TGF-BETA #PLASTICITY #INFLAMMATION #EXPRESSION #RECEPTOR #IMMUNOLOGY
Tipo

article

original article

publishedVersion